Heme oxygenase-1: emerging target of cancer therapy

Journal of Biomedical Science

Lee-Young Chau¹ 

[1] Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan

关键词: Tumorigenesis;    Inflammation;    Oxidative stress;    Heme oxygenase-1;   

Others  :  1146110
DOI  :  10.1186/s12929-015-0128-0

 received in 2015-01-13, accepted in 2015-03-09,  发布年份 2015

【 摘 要 】

Heme oxygenase-1 (HO-1) is a rate-limiting enzyme catalyzing oxidative degradation of cellular heme to liberate free iron, carbon monoxide (CO) and biliverdin in mammalian cells. In addition to its primary role in heme catabolism, HO-1 exhibits anti-oxidative and anti-inflammatory functions via the actions of biliverdin and CO, respectively. HO-1 is highly induced in various disease states, including cancer. Several lines of evidence have supported the implication of HO-1 in carcinogenesis and tumor progression. HO-1 deficiency in normal cells enhances DNA damage and carcinogenesis. Nevertheless, HO-1 overexpression in cancer cells promotes proliferation and survival. Moreover, HO-1 induces angiogenesis through modulating expression of angiogenic factors. Although HO-1 is an endoplasmic reticulum resident protein, HO-1 nuclear localization is evident in tumor cells of cancer tissues. It has been shown that HO-1 is susceptible to proteolytic cleavage and translocates to nucleus to facilitate tumor growth and invasion independent of its enzymatic activity. HO-1 also impacts cancer progression through modulating tumor microenvironment. This review summarizes the current understanding of the protumorigenic role of HO-1 and its potential as a molecular target for cancer therapy.

【 授权许可】

   
2015 Chau; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Maines MD: Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988, 2:2557-68.
• [2]Alam J, Shibahara S, Smith A: Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem 1989, 264:6371-5.
• [3]Keyse SM, Applegate LA, Tromvoukis Y, Tyrrell RM: Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts. Mol Cell Biol 1990, 10:4967-9.
• [4]Rizzardini M, Terao M, Falciani F, Cantoni L: Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J 1993, 290(Pt 2):343-7.
• [5]Cantoni L, Rossi C, Rizzardini M, Gadina M, Ghezzi P, Cantoni L, et al.: Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J 1991, 279(Pt 3):891-4.
• [6]Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, et al.: Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997, 272:5375-81.
• [7]Poss KD, Tonegawa S: Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A 1997, 94:10925-30.
• [8]Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, et al.: Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999, 103:R23-9.
• [9]Liu X, Wei J, Peng DH, Layne MD, Yet SF: Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes 2005, 54:778-84.
• [10]Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al.: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103:129-35.
• [11]Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235:1043-6.
• [12]Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al.: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000, 6:422-8.
• [13]Abraham NG, Kappas A: Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008, 60:79-127.
• [14]Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, et al.: Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002, 111:1-8.
• [15]Chang KW, Lee TC, Yeh WI, Chung MY, Liu CJ, Chi LY, et al.: Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 2004, 91:1551-5.
• [16]Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, et al.: Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 2005, 116:354-60.
• [17]Okamoto I, Krogler J, Endler G, Kaufmann S, Mustafa S, Exner M, et al.: A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma. Int J Cancer 2006, 119:1312-5.
• [18]Lo SS, Lin SC, Wu CW, Chen JH, Yeh WI, Chung MY, et al.: Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann Surg Oncol 2007, 14:2250-6.
• [19]Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, et al.: Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2007, 16:1784-94.
• [20]Sawa T, Mounawar M, Tatemichi M, Gilibert I, Katoh T, Ohshima H: Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters. Cancer Lett 2008, 269:78-84.
• [21]Hu JL, Li ZY, Liu W, Zhang RG, Li GL, Wang T, et al.: Polymorphism in heme oxygenase-1 (HO-1) promoter and alcohol are related to the risk of esophageal squamous cell carcinoma on Chinese males. Neoplasma 2010, 57:86-92.
• [22]Vashist YK, Uzungolu G, Kutup A, Gebauer F, Koenig A, Deutsch L, et al.: Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer. J Surg Oncol 2011, 104:305-11.
• [23]Murakami A, Fujimori Y, Yoshikawa Y, Yamada S, Tamura K, Hirayama N, et al.: Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma. Lung 2012, 190:333-7.
• [24]Zhang L, Song FF, Huang YB, Zheng H, Song FJ, Chen KX: Association between the (GT)n polymorphism of the HO-1 gene promoter region and cancer risk: a meta-analysis. Asian Pac J Cancer Prev 2014, 15:4617-22.
• [25]Maines MD, Abrahamsson PA: Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology 1996, 47:727-33.
• [26]Goodman AI, Choudhury M, da Silva JL, Schwartzman ML, Abraham NG: Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 1997, 214:54-61.
• [27]Yin Y, Liu Q, Wang B, Chen G, Xu L, Zhou H: Expression and function of heme oxygenase-1 in human gastric cancer. Exp Biol Med (Maywood) 2012, 237:362-71.
• [28]Yin H, Fang J, Liao L, Maeda H, Su Q: Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity. BMC Cancer 2014, 14:436. BioMed Central Full Text
• [29]Degese MS, Mendizabal JE, Gandini NA, Gutkind JS, Molinolo A, Hewitt SM, et al.: Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data. Lung Cancer 2012, 77:168-75.
• [30]Wang TY, Liu CL, Chen MJ, Lee JJ, Pun PC, Cheng SP. Expression of heme oxygenase-1 correlates with tumor aggressiveness and BRAF expression in thyroid cancer. Histopathology 2014, Sep 29. doi:10.1111/his.12562.
• [31]Miyata Y, Kanda S, Mitsunari K, Asai A, Sakai H: Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity. Transl Res 2014, 164:468-76.
• [32]Noh SJ, Bae JS, Jamiyandorj U, Park HS, Kwon KS, Jung SH, et al.: Expression of nerve growth factor and heme oxygenase-1 predict poor survival of breast carcinoma patients. BMC Cancer 2013, 13:516. BioMed Central Full Text
• [33]Tsuji MH, Yanagawa T, Iwasa S, Tabuchi K, Onizawa K, Bannai S, et al.: Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett 1999, 138:53-9.
• [34]Gandini NA, Fermento ME, Salomon DG, Obiol DJ, Andres NC, Zenklusen JC, et al.: Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma. Tumour Biol 2014, 35:2803-15.
• [35]Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N, et al.: Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer 2007, 97:1683-9.
• [36]Wegiel B, Gallo D, Csizmadia E, Harris C, Belcher J, Vercellotti GM, et al.: Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res 2013, 73:7009-21.
• [37]Hsu FF, Yeh CT, Sun YJ, Chiang MT, Lan WM, Li FA et al. Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity. Oncogene 2014. doi: 10.1038/onc.2014.166.
• [38]Gandini NA, Fermento ME, Salomon DG, Blasco J, Patel V, Gutkind JS, et al.: Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. Exp Mol Pathol 2012, 93:237-45.
• [39]Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, et al.: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 1999, 5:1107-13.
• [40]Torisu-Itakura H, Furue M, Kuwano M, Ono M: Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Jpn J Cancer Res 2000, 91:906-10.
• [41]Boschetto P, Zeni E, Mazzetti L, Miotto D, Lo Cascio N, Maestrelli P, et al.: Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancer. Lung Cancer 2008, 59:192-7.
• [42]Quail DF, Joyce JA: Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013, 19:1423-37.
• [43]Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A 1994, 91:5987-91.
• [44]McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, et al.: Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 2004, 103:3465-73.
• [45]Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, et al.: Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res 2004, 64:3148-54.
• [46]Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, et al.: Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal 2013, 19:644-60.
• [47]Gao C, Peng FH, Peng LK: MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1. Neoplasma 2014, 61:680-9.
• [48]Lin PH, Chiang MT, Chau LY: Ubiquitin-proteasome system mediates heme oxygenase-1 degradation through endoplasmic reticulum-associated degradation pathway. Biochim Biophys Acta 2008, 1783:1826-34.
• [49]Lin PH, Lan WM, Chau LY: TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation. Oncogene 2013, 32:2325-34.
• [50]Otterbein LE, Hedblom A, Harris C, Csizmadia E, Gallo D, Wegiel B: Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein. Proc Natl Acad Sci U S A 2011, 108:14491-6.
• [51]Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, et al.: Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 2003, 6:15-24.
• [52]Chen GG, Liu ZM, Vlantis AC, Tse GM, Leung BC, van Hasselt CA: Heme oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J Cell Biochem 2004, 92:1246-56.
• [53]Was H, Cichon T, Smolarczyk R, Rudnicka D, Stopa M, Chevalier C, et al.: Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice. Am J Pathol 2006, 169:2181-98.
• [54]Liu ZM, Chen GG, Ng EK, Leung WK, Sung JJ, Chung SC: Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 2004, 23:503-13.
• [55]Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Kunzli B, et al.: Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 2005, 11:3790-8.
• [56]Kweon MH, Adhami VM, Lee JS, Mukhtar H: Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 2006, 281:33761-72.
• [57]Kocanova S, Buytaert E, Matroule JY, Piette J, Golab J, de Witte P, et al.: Induction of heme-oxygenase 1 requires the p38MAPK and PI3K pathways and suppresses apoptotic cell death following hypericin-mediated photodynamic therapy. Apoptosis 2007, 12:731-41.
• [58]Nuhn P, Kunzli BM, Hennig R, Mitkus T, Ramanauskas T, Nobiling R, et al.: Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo. Mol Cancer 2009, 8:37. BioMed Central Full Text
• [59]Furfaro AL, Piras S, Passalacqua M, Domenicotti C, Parodi A, Fenoglio D, et al.: HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. Biochim Biophys Acta 1842, 2014:613-22.
• [60]Liu YS, Li HS, Qi DF, Zhang J, Jiang XC, Shi K, et al.: Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin. World J Gastroenterol 2014, 20:8572-82.
• [61]Kongpetch S, Kukongviriyapan V, Prawan A, Senggunprai L, Kukongviriyapan U, Buranrat B: Crucial role of heme oxygenase-1 on the sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. PLoS One 2012, 7:e34994.
• [62]Yamamoto T, Takano N, Ishiwata K, Ohmura M, Nagahata Y, Matsuura T, et al.: Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway. Nat Commun 2014, 5:3480.
• [63]Sass G, Leukel P, Schmitz V, Raskopf E, Ocker M, Neureiter D, et al.: Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice. Int J Cancer 2008, 123:1269-77.
• [64]Miyake M, Fujimoto K, Anai S, Ohnishi S, Kuwada M, Nakai Y, et al.: Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. Oncol Rep 2011, 25:653-60.
• [65]Birrane G, Li H, Yang S, Tachado SD, Seng S: Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion. Int J Oncol 2013, 42:1919-28.
• [66]DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al.: Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-9.
• [67]Geismann C, Arlt A, Sebens S, Schafer H: Cytoprotection “gone astray”: Nrf2 and its role in cancer. Onco Targets Ther 2014, 7:1497-518.
• [68]Sporn MB, Liby KT: NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012, 12:564-71.
• [69]Alaoui-Jamali MA, Bismar TA, Gupta A, Szarek WA, Su J, Song W, et al.: A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer. Cancer Res 2009, 69:8017-24.
• [70]Mayerhofer M, Gleixner KV, Mayerhofer J, Hoermann G, Jaeger E, Aichberger KJ, et al.: Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib. Blood 2008, 111:2200-10.
• [71]Miyake M, Fujimoto K, Anai S, Ohnishi S, Nakai Y, Inoue T, et al.: Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells. Anticancer Res 2010, 30:2145-52.
• [72]Frezza C, Zheng L, Folger O, Rajagopalan KN, MacKenzie ED, Jerby L, et al.: Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 2011, 477:225-8.
• [73]Wang XM, Kim HP, Nakahira K, Ryter SW, Choi AM: The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J Immunol 2009, 182:3809-18.
• [74]Converso DP, Taille C, Carreras MC, Jaitovich A, Poderoso JJ, Boczkowski J: HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 2006, 20:1236-8.
• [75]Bindu S, Pal C, Dey S, Goyal M, Alam A, Iqbal MS, et al.: Translocation of heme oxygenase-1 to mitochondria is a novel cytoprotective mechanism against non-steroidal anti-inflammatory drug-induced mitochondrial oxidative stress, apoptosis, and gastric mucosal injury. J Biol Chem 2011, 286:39387-402.
• [76]Suttner DM, Sridhar K, Lee CS, Tomura T, Hansen TN, Dennery PA: Protective effects of transient HO-1 overexpression on susceptibility to oxygen toxicity in lung cells. Am J Physiol 1999, 276:L443-51.
• [77]Giordano A, Nisoli E, Tonello C, Cancello R, Carruba MO, Cinti S: Expression and distribution of heme oxygenase-1 and −2 in rat brown adipose tissue: the modulatory role of the noradrenergic system. FEBS Lett 2000, 487:171-5.
• [78]Li Volti G, Ientile R, Abraham NG, Vanella A, Cannavo G, Mazza F, et al.: Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial cell cultures during differentiation: effect of glutamate. Biochem Biophys Res Commun 2004, 315:517-24.
• [79]Yoshida T, Ishikawa K, Sato M: Degradation of heme by a soluble peptide of heme oxygenase obtained from rat liver microsomes by mild trypsinization. Eur J Biochem 1991, 199:729-33.
• [80]Lin Q, Weis S, Yang G, Weng YH, Helston R, Rish K, et al.: Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem 2007, 282:20621-33.
• [81]Boname JM, Bloor S, Wandel MP, Nathan JA, Antrobus R, Dingwell KS, et al.: Cleavage by signal peptide peptidase is required for the degradation of selected tail-anchored proteins. J Cell Biol 2014, 205:847-62.
• [82]Tibullo D, Barbagallo I, Giallongo C, La Cava P, Parrinello N, Vanella L, et al.: Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells. Curr Pharm Des 2013, 19:2765-70.
• [83]Collinson EJ, Wimmer-Kleikamp S, Gerega SK, Yang YH, Parish CR, Dawes IW, et al.: The yeast homolog of heme oxygenase-1 affords cellular antioxidant protection via the transcriptional regulation of known antioxidant genes. J Biol Chem 2011, 286:2205-14.
• [84]Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, et al.: Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004, 103:761-6.
• [85]De Wilde V, Van Rompaey N, Hill M, Lebrun JF, Lemaitre P, Lhomme F, et al.: Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009, 9:2034-47.
• [86]Arnold JN, Magiera L, Kraman M, Fearon DT: Tumoral immune suppression by macrophages expressing fibroblast activation protein-alpha and heme oxygenase-1. Cancer Immunol Res 2014, 2:121-6.
• [87]Lin HH, Chiang MT, Chang PC, Chau LY. Myeloid heme oxygenase-1 promotes metastatic tumor colonization in mice. Cancer Sci, In press.
• [88]Andersen MH, Sorensen RB, Brimnes MK, Svane IM, Becker JC, Thor Straten P: Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J Clin Invest 2009, 119:2245-56.
• [89]Pittala V, Salerno L, Romeo G, Modica MN, Siracusa MA: A focus on heme oxygenase-1 (HO-1) inhibitors. Curr Med Chem 2013, 20:3711-32.
• [90]Salerno L, Pittala V, Romeo G, Modica MN, Siracusa MA, Di Giacomo C, et al.: Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. Bioorg Med Chem 2013, 21:5145-53.